Table 3 Odds ratio and adjusted odds ratio for obstetric outcomes associated with SARS-CoV-2 exposure in pregnancy
Outcomes | |||||
|---|---|---|---|---|---|
Preterm delivery | Spontaneous preterm delivery | PROM | PPROM | NICU admission | |
Univariate analysis (OR) | |||||
SARS-CoV-2 positive | 2.23 | 1.31 | 1.72 | 2.33 | 4.27 |
95% CI | 1.41–3.54 | 0.69–2.39 | 1.14–2.62 | 1.06–5.15 | 2.26–8.05 |
p-value | 0.001 | 0.390 | 0.009 | 0.031 | 0.001 |
Multivariate analysis (aOR) | |||||
SARS-CoV-2 positive | 2.12 | 1.10 | 1.70 | 2.26 | 4.62 |
95% CI | 1.32–3.36 | 0.57–2.06 | 1.11–2.57 | 0.99–4.98 | 2.43–8.94 |
p-value | 0.002 | 0.760 | 0.013 | 0.045 | < 0.001 |
In Vitro Fertilization | 2.37 | – | – | – | – |
95% CI | 0.97–5.16 | – | – | – | – |
p-value | 0.041 | – | – | – | – |
Miscarriage Risk | 2.61 | 4.19 | – | 2.69 | – |
95% CI | 0.92–6.42 | 1.35–10.88 | – | 0.42–9.91 | – |
p-value | 0.050 | 0.006 | – | 0.198 | – |
Ethnicity | |||||
Latin American vs White European | – | 2.11 (1.04–4.09) | – | – | – |
Other Ethnic Groups vs White European | – | 0.38 (0.06–1.27) | – | – | – |
p-value | – | 0.031 and 0.188 | – | – | – |
Multiple pregnancy | – | – | 1.86*10−7 | – | 3.72 |
95% CI | – | – | 0.00 – . | – | 1.02–10.73 |
p-value | – | – | 0.981 | – | 0.025 |
Gestational Hypertensive Disorders | – | – | – | – | 3.63 |
95% CI | – | – | – | – | 1.28–8.91 |
p-value | – | – | – | – | 0.008 |